KGX-103

N/A

Report date: 2024/11/22 14:26:06

Base Information

Drug NameKGX-103
Drug Alias NameKGX-103KGX103KGX-103（细胞因子前药分子）
ClassificationBiologics
Mechanisms of ActionInterleukins replacements
TargetsInterleukins
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai KangaBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai KangaBio Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A